| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | - ISIN |
| KR Country | - Employees | 29 Dec 2025 Last Dividend | 15 Jun 2021 Last Split | - IPO Date |
Korea Arlico Pharm Co.,Ltd., established in 1992 and based in Seoul, South Korea, is a prominent entity in the pharmaceutical industry. The company specializes in researching, developing, producing, and selling a wide range of medicines within the South Korean market. Korea Arlico Pharm Co.,Ltd.'s product portfolio includes ETC, OTC, medical devices, and other products alongside active ingredients. With its comprehensive approach toward healthcare, the company caters to a broad spectrum of medical needs, touching upon various diseases and health concerns. The dedication towards innovation and quality has positioned Korea Arlico Pharm Co.,Ltd. as a key player in the pharmaceutical sector.
Korea Arlico Pharm Co.,Ltd. provides a diverse range of products and services, each designed to meet specific health requirements. Here's a breakdown of their offerings:
The company's therapeutic areas include: